Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan · Delayed Price · Currency is TWD 40.00
-2.20 (-5.21%)
At close: Mar 27, 2026
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 1.59 billion as of March 27, 2026. Its market cap has decreased by -26.50% in one year.
Market Cap
1.59B
Enterprise Value
1.63B
Revenue
698.11M
Ranking
n/a
PE Ratio
45.08
Stock Price
40.00
Market Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has decreased from 1.68B to 1.59B, a decrease of -5.41%. That is a compound annual growth rate of -1.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.59B | -36.51% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
| Jan 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| A Plus Biotechnology | 2.74B |
| Dynamic Medical Technologies | 2.43B |
| Applied BioCode | 2.40B |
| Wellell | 2.26B |
| Taiwan Biomaterial | 1.89B |
| OK Biotech | 1.88B |
| Bioptik Technology Incorporation | 1.52B |
| Cowealth Medical Holding | 1.47B |